Higher  ||| S:0 E:7 ||| JJR
protein  ||| S:7 E:15 ||| NN
intake  ||| S:15 E:22 ||| NN
strategies  ||| S:22 E:33 ||| NNS
in  ||| S:33 E:36 ||| IN
human  ||| S:36 E:42 ||| JJ
milk  ||| S:42 E:47 ||| NN
fortification  ||| S:47 E:61 ||| NN
for  ||| S:61 E:65 ||| IN
preterms  ||| S:65 E:74 ||| JJ
infants  ||| S:74 E:82 ||| JJ
feeding ||| S:82 E:89 ||| NN
.  ||| S:89 E:91 ||| .
Auxological  ||| S:91 E:103 ||| NNP
and  ||| S:103 E:107 ||| CC
neurodevelopmental  ||| S:107 E:126 ||| JJ
outcome  ||| S:126 E:134 ||| NN
Postnatal  ||| S:134 E:144 ||| NNP
growth  ||| S:144 E:151 ||| NN
restriction  ||| S:151 E:163 ||| NN
and  ||| S:163 E:167 ||| CC
failure  ||| S:167 E:175 ||| NN
to  ||| S:175 E:178 ||| TO
thrive  ||| S:178 E:185 ||| VB
still  ||| S:185 E:191 ||| RB
remain  ||| S:191 E:198 ||| VB
a  ||| S:198 E:200 ||| DT
major  ||| S:200 E:206 ||| JJ
problem  ||| S:206 E:214 ||| NN
in  ||| S:214 E:217 ||| IN
Extremely  ||| S:217 E:227 ||| NNP
Low  ||| S:227 E:231 ||| NNP
Birth  ||| S:231 E:237 ||| NNP
Weight  ||| S:237 E:244 ||| NNP
( ||| S:244 E:245 ||| -LRB-
ELBW ||| S:245 E:249 ||| NNP
)  ||| S:249 E:251 ||| -RRB-
infants  ||| S:251 E:259 ||| NNS
.  ||| S:259 E:261 ||| .
The  ||| S:261 E:265 ||| DT
goal  ||| S:265 E:270 ||| NN
for  ||| S:270 E:274 ||| IN
the  ||| S:274 E:278 ||| DT
nutritional  ||| S:278 E:290 ||| JJ
care  ||| S:290 E:295 ||| NN
of  ||| S:295 E:298 ||| IN
these  ||| S:298 E:304 ||| DT
infants  ||| S:304 E:312 ||| NN
is  ||| S:312 E:315 ||| VBZ
to  ||| S:315 E:318 ||| TO
achieve  ||| S:318 E:326 ||| VB
rate  ||| S:326 E:331 ||| NN
of  ||| S:331 E:334 ||| IN
growth  ||| S:334 E:341 ||| NN
similar  ||| S:341 E:349 ||| JJ
to  ||| S:349 E:352 ||| TO
those  ||| S:352 E:358 ||| DT
of  ||| S:358 E:361 ||| IN
the  ||| S:361 E:365 ||| DT
fetus  ||| S:365 E:371 ||| NN
in  ||| S:371 E:374 ||| IN
utero  ||| S:374 E:380 ||| NN
at  ||| S:380 E:383 ||| IN
the  ||| S:383 E:387 ||| DT
equivalent  ||| S:387 E:398 ||| JJ
gestational  ||| S:398 E:410 ||| JJ
age ||| S:410 E:413 ||| NN
.  ||| S:413 E:415 ||| .
Human  ||| S:415 E:421 ||| JJ
milk  ||| S:421 E:426 ||| NN
fortified  ||| S:426 E:436 ||| NN
remains  ||| S:436 E:444 ||| VBZ
the  ||| S:444 E:448 ||| DT
best  ||| S:448 E:453 ||| JJS
food  ||| S:453 E:458 ||| NN
for  ||| S:458 E:462 ||| IN
all  ||| S:462 E:466 ||| PDT
these  ||| S:466 E:472 ||| DT
preterms ||| S:472 E:480 ||| NN
.  ||| S:480 E:482 ||| .
Two  ||| S:482 E:486 ||| CD
groups  ||| S:486 E:493 ||| NNS
of  ||| S:493 E:496 ||| IN
preterm  ||| S:496 E:504 ||| NN
of  ||| S:504 E:507 ||| IN
weight  ||| S:507 E:514 ||| NN
580-1250  ||| S:514 E:523 ||| CD
g  ||| S:523 E:525 ||| NNS
and  ||| S:525 E:529 ||| CC
gestational  ||| S:529 E:541 ||| JJ
age  ||| S:541 E:545 ||| NN
23-32  ||| S:545 E:551 ||| CD
wk ||| S:551 E:553 ||| NN
,  ||| S:553 E:555 ||| ,
were  ||| S:555 E:560 ||| VBD
fed  ||| S:560 E:564 ||| VBN
with  ||| S:564 E:569 ||| IN
different  ||| S:569 E:579 ||| JJ
protein  ||| S:579 E:587 ||| NN
intake  ||| S:587 E:594 ||| NN
in  ||| S:594 E:597 ||| IN
the  ||| S:597 E:601 ||| DT
human ||| S:601 E:606 ||| JJ
/ ||| S:606 E:607 ||| FW
maternal  ||| S:607 E:616 ||| FW
milk  ||| S:616 E:621 ||| FW
fortified  ||| S:621 E:631 ||| FW
(  ||| S:631 E:633 ||| -LRB-
3 ||| S:633 E:634 ||| LS
, ||| S:634 E:635 ||| ,
5  ||| S:635 E:637 ||| CD
g  ||| S:637 E:639 ||| CD
Kg-1  ||| S:639 E:644 ||| CD
per  ||| S:644 E:648 ||| IN
day  ||| S:648 E:652 ||| NN
and  ||| S:652 E:656 ||| CC
4 ||| S:656 E:657 ||| CD
, ||| S:657 E:658 ||| ,
8  ||| S:658 E:660 ||| CD
g  ||| S:660 E:662 ||| CD
Kg-1  ||| S:662 E:667 ||| CD
per  ||| S:667 E:671 ||| IN
day  ||| S:671 E:675 ||| NN
in  ||| S:675 E:678 ||| IN
the  ||| S:678 E:682 ||| DT
control  ||| S:682 E:690 ||| NN
and  ||| S:690 E:694 ||| CC
intervention  ||| S:694 E:707 ||| NN
group  ||| S:707 E:713 ||| NN
respectively ||| S:713 E:725 ||| RB
) ||| S:725 E:726 ||| -RRB-
.The  ||| S:726 E:731 ||| VBP
feeding  ||| S:731 E:739 ||| VBG
tolerance ||| S:739 E:748 ||| NN
,  ||| S:748 E:750 ||| ,
intrahospital  ||| S:750 E:764 ||| JJ
growth ||| S:764 E:770 ||| NN
,  ||| S:770 E:772 ||| ,
neurological  ||| S:772 E:785 ||| JJ
outcome  ||| S:785 E:793 ||| NN
and  ||| S:793 E:797 ||| CC
anthropometric  ||| S:797 E:812 ||| JJ
data  ||| S:812 E:817 ||| NNS
until  ||| S:817 E:823 ||| IN
12  ||| S:823 E:826 ||| CD
months  ||| S:826 E:833 ||| NNS
of  ||| S:833 E:836 ||| IN
corrected  ||| S:836 E:846 ||| JJ
age ||| S:846 E:849 ||| NN
,  ||| S:849 E:851 ||| ,
were  ||| S:851 E:856 ||| VBD
evaluated ||| S:856 E:865 ||| VBN
.  ||| S:865 E:867 ||| .
The  ||| S:867 E:871 ||| DT
protein  ||| S:871 E:879 ||| NN
supplemented  ||| S:879 E:892 ||| NN
group  ||| S:892 E:898 ||| NN
( ||| S:898 E:899 ||| -LRB-
PSG ||| S:899 E:902 ||| NNP
)  ||| S:902 E:904 ||| -RRB-
showed  ||| S:904 E:911 ||| VBD
an  ||| S:911 E:914 ||| DT
intrahospital  ||| S:914 E:928 ||| JJ
highter  ||| S:928 E:936 ||| JJ
growth  ||| S:936 E:943 ||| NN
rate  ||| S:943 E:948 ||| NN
(  ||| S:948 E:950 ||| -LRB-
mostly  ||| S:950 E:957 ||| RB
in  ||| S:957 E:960 ||| IN
head  ||| S:960 E:965 ||| NN
circumference ||| S:965 E:978 ||| NN
,  ||| S:978 E:980 ||| ,
p  ||| S:980 E:982 ||| CD
0,02 ||| S:982 E:986 ||| CD
,  ||| S:986 E:988 ||| ,
and  ||| S:988 E:992 ||| CC
length  ||| S:992 E:999 ||| NN
growth ||| S:999 E:1005 ||| NN
,  ||| S:1005 E:1007 ||| ,
p  ||| S:1007 E:1009 ||| CD
0,04 ||| S:1009 E:1013 ||| CD
)  ||| S:1013 E:1015 ||| -RRB-
only  ||| S:1015 E:1020 ||| RB
in  ||| S:1020 E:1023 ||| IN
the  ||| S:1023 E:1027 ||| DT
preterms  ||| S:1027 E:1036 ||| NN
with  ||| S:1036 E:1041 ||| IN
580-980  ||| S:1041 E:1049 ||| CD
g  ||| S:1049 E:1051 ||| NNS
and  ||| S:1051 E:1055 ||| CC
23-30  ||| S:1055 E:1061 ||| CD
wk ||| S:1061 E:1063 ||| NNS
.  ||| S:1063 E:1065 ||| .
In  ||| S:1065 E:1068 ||| IN
the  ||| S:1068 E:1072 ||| DT
same  ||| S:1072 E:1077 ||| JJ
preterms ||| S:1077 E:1085 ||| NN
,  ||| S:1085 E:1087 ||| ,
Griffith  ||| S:1087 E:1096 ||| NNP
Development  ||| S:1096 E:1108 ||| NNP
Mental  ||| S:1108 E:1115 ||| NNP
Score  ||| S:1115 E:1121 ||| NN
at  ||| S:1121 E:1124 ||| IN
3  ||| S:1124 E:1126 ||| CD
and  ||| S:1126 E:1130 ||| CC
12  ||| S:1130 E:1133 ||| CD
months  ||| S:1133 E:1140 ||| NNS
corrected  ||| S:1140 E:1150 ||| VBN
age  ||| S:1150 E:1154 ||| NN
showed  ||| S:1154 E:1161 ||| VBD
higher  ||| S:1161 E:1168 ||| JJR
score  ||| S:1168 E:1174 ||| NN
than  ||| S:1174 E:1179 ||| IN
in  ||| S:1179 E:1182 ||| IN
the  ||| S:1182 E:1186 ||| DT
control  ||| S:1186 E:1194 ||| NN
group  ||| S:1194 E:1200 ||| NN
in  ||| S:1200 E:1203 ||| IN
the  ||| S:1203 E:1207 ||| DT
Performance  ||| S:1207 E:1219 ||| NNP
( ||| S:1219 E:1220 ||| -LRB-
p  ||| S:1220 E:1222 ||| FW
0,04 ||| S:1222 E:1226 ||| FW
)  ||| S:1226 E:1228 ||| -RRB-
and  ||| S:1228 E:1232 ||| CC
Hearing ||| S:1232 E:1239 ||| NNP
/ ||| S:1239 E:1240 ||| NNP
Language  ||| S:1240 E:1249 ||| NNP
( ||| S:1249 E:1250 ||| -LRB-
p  ||| S:1250 E:1252 ||| FW
0,03 ||| S:1252 E:1256 ||| FW
)  ||| S:1256 E:1258 ||| -RRB-
items ||| S:1258 E:1263 ||| NNS
.  ||| S:1263 E:1265 ||| .
The  ||| S:1265 E:1269 ||| DT
auxological  ||| S:1269 E:1281 ||| JJ
evaluation  ||| S:1281 E:1292 ||| NN
in  ||| S:1292 E:1295 ||| IN
the  ||| S:1295 E:1299 ||| DT
postdischarge  ||| S:1299 E:1313 ||| JJ
period  ||| S:1313 E:1320 ||| NN
showed  ||| S:1320 E:1327 ||| VBD
in  ||| S:1327 E:1330 ||| IN
the  ||| S:1330 E:1334 ||| DT
PSG  ||| S:1334 E:1338 ||| NNP
group  ||| S:1338 E:1344 ||| NN
mean  ||| S:1344 E:1349 ||| VBP
z-score  ||| S:1349 E:1357 ||| JJ
values  ||| S:1357 E:1364 ||| NNS
for  ||| S:1364 E:1368 ||| IN
length  ||| S:1368 E:1375 ||| NN
higher  ||| S:1375 E:1382 ||| JJR
than  ||| S:1382 E:1387 ||| IN
those  ||| S:1387 E:1393 ||| DT
in  ||| S:1393 E:1396 ||| IN
the  ||| S:1396 E:1400 ||| DT
control  ||| S:1400 E:1408 ||| NN
group  ||| S:1408 E:1414 ||| NN
at  ||| S:1414 E:1417 ||| IN
9  ||| S:1417 E:1419 ||| CD
( ||| S:1419 E:1420 ||| -LRB-
p  ||| S:1420 E:1422 ||| FW
0,04 ||| S:1422 E:1426 ||| FW
)  ||| S:1426 E:1428 ||| -RRB-
months  ||| S:1428 E:1435 ||| NNS
of  ||| S:1435 E:1438 ||| IN
corrected  ||| S:1438 E:1448 ||| JJ
age ||| S:1448 E:1451 ||| NN
.  ||| S:1451 E:1453 ||| .
